Fenofibrate Treatment of Diabetic Rats Reduces Nitrosative Stress, Renal Cyclooxygenase-2 Expression, and Enhanced Renal Prostaglandin Release

Nitric Oxide and Peroxynitrite in Health and Disease

Pacher, P., Beckman, J. S., & Liaudet, L. (2007) · Physiological Reviews · doi:10.1152/physrev.00029.2006 · Cited by 6,390 · see citing works

Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage

Nishikawa, T., Edelstein, D., Du, X. L., Yamagishi, S.-I., Matsumura, T., Kaneda, Y., Yorek, M. A., Beebe, D., Oates, P. J., Hammes, H.-P., et al. (2000) · Nature · doi:10.1038/35008121 · Cited by 4,277 · see citing works

The mechanisms of action of PPARs

Berger, J., & Moller, D. E. (2002) · Annual Review of Medicine · doi:10.1146/annurev.med.53.082901.104018 · Cited by 2,659 · see citing works

High Glucose Causes Upregulation of Cyclooxygenase-2 and Alters Prostanoid Profile in Human Endothelial Cells

Cosentino, F., Eto, M., Paolis, P. D., van der Loo, B., Bachschmid, M. M., Ullrich, V., Kouroedov, A., Gatti, C., Joch, H., Volpe, M., et al. (2003) · Circulation · doi:10.1161/01.cir.0000051367.92927.07 · Cited by 419 · see citing works

Oxidative stress and nitric oxide synthase in rat diabetic nephropathy: Effects of ACEI and ARB

Onozato, M. L., Tojo, A., Goto, A., Fujita, T., & Wilcox, C. S. (2002) · Kidney International · doi:10.1046/j.1523-1755.2002.00123.x · Cited by 374 · see citing works

Reactive Oxygen Species from Mitochondria Induce Cyclooxygenase-2 Gene Expression in Human Mesangial Cells

Kiritoshi, S., Nishikawa, T., Sonoda, K., Kukidome, D., Senokuchi, T., Matsuo, T., Matsumura, T., Tokunaga, H., Brownlee, M., & Araki, E. (2003) · Diabetes · doi:10.2337/diabetes.52.10.2570 · Cited by 345 · see citing works

The ligands/activators for peroxisome proliferator-activated receptor α (PPARα) and PPARγ increase Cu2+, Zn2+-superoxide dismutase and decrease p22phox message expressions in primary endothelial cells

Inoue, I., Goto, S.-I., Matsunaga, T., Nakajima, T., Awata, T., Hokari, S., Komoda, T., & Katayama, S. (2001) · Metabolism · doi:10.1053/meta.2001.19415 · Cited by 283 · see citing works

Peroxisome Proliferator-Activated Receptor (PPAR)-α: A Pharmacological Target with a Promising Future

van Raalte, D. H., Li, M., Pritchard, P. H., & Wasan, K. M. (2004) · Pharmaceutical Research · doi:10.1023/b:pham.0000041444.06122.8d · Cited by 269 · see citing works

Increased expression of NAD(P)H oxidase subunits, NOX4 and p22phox, in the kidney of streptozotocin-induced diabetic rats and its reversibity by interventive insulin treatment

Etoh, T., Inoguchi, T., Kakimoto, M., Sonoda, N., Kobayashi, K., Kuroda, J., Sumimoto, H., & Nawata, H. (2003) · Diabetologia · doi:10.1007/s00125-003-1205-6 · Cited by 253 · see citing works

PPARα agonist fenofibrate improves diabetic nephropathy in db/db mice

Park, C. W., Zhang, Y., Zhang, X., Wu, J., Chen, L., Cha, D. R., Su, D., Hwang, M.-T., Fan, X., Davis, L., et al. (2006) · Kidney International · doi:10.1038/sj.ki.5000209 · Cited by 202 · see citing works

Cyclooxygenase-2 inhibitor blocks expression of mediators of renal injury in a model of diabetes and hypertension1

Cheng, H., Wang, C. J., Moeckel, G. W., Zhang, M., McKanna, J. A., & Harris, R. C. (2002) · Kidney International · doi:10.1046/j.1523-1755.2002.00520.x · Cited by 192 · see citing works

Immunohistochemical and functional correlations of renal cyclooxygenase-2 in experimental diabetes

Komers, R., Lindsley, J. N., Oyama, T., Schutzer, W. E., Reed, J. F., Mader, S. L., & Anderson, S. (2001) · Journal of Clinical Investigation · doi:10.1172/jci10228 · Cited by 187 · see citing works

Nitric Oxide Synthase Isoforms and Glomerular Hyperfiltration in Early Diabetic Nephropathy

Veelken, R. A., Hilgers, K. F., Hartner, A., HAAS, A., DiaeresisHMER, K. P. B., & Sterzel, R. B. (2000) · Journal of the American Society of Nephrology · doi:10.1681/asn.v11171 · Cited by 181 · see citing works

Poly(ADP-Ribose) Polymerase Is Activated in Subjects at Risk of Developing Type 2 Diabetes and Is Associated With Impaired Vascular Reactivity

Szabó, C., Zanchi, A., Komjáti, K., Pacher, P., Królewski, A. S., Quist, W. C., LoGerfo, F. W., Horton, E. S., & Veves, A. (2002) · Circulation · doi:10.1161/01.cir.0000038365.78031.9c · Cited by 171 · see citing works

Increased prostaglandin production by glomeruli isolated from rats with streptozotocin-induced diabetes mellitus.

Schambelan, M., Blake, S., Sraer, J., Bens, M., Nivez, M.-P., & Wahbe, F. (1985) · Journal of Clinical Investigation · doi:10.1172/jci111714 · Cited by 170 · see citing works

Glucose-induced oxidative stress in mesangial cells

Catherwood, M. A., Powell, L. A., Anderson, P., McMaster, D., Sharpe, P. C., & Trimble, E. R. (2002) · Kidney International · doi:10.1046/j.1523-1755.2002.00168.x · Cited by 170 · see citing works

Sequential alterations in glomerular prostaglandin and thromboxane synthesis in diabetic rats: Relationship to the hyperfiltration of early diabetes

Craven, P. A., Caines, M. A., & DeRubertis, F. R. (1987) · Metabolism · doi:10.1016/0026-0495(87)90070-9 · Cited by 166 · see citing works

Fenofibrate Therapy Ameliorates Fasting and Postprandial Lipoproteinemia, Oxidative Stress, and the Inflammatory Response in Subjects With Hypertriglyceridemia and the Metabolic Syndrome

Rosenson, R. S., Wolff, D. A., Huskin, A. L., Helenowski, I. B., & Rademaker, A. W. (2007) · Diabetes Care · doi:10.2337/dc07-0015 · Cited by 117 · see citing works

Increased nitrotyrosine staining in kidneys from patients with diabetic nephropathy

Thuraisingham, R. C., Nott, C. A., Dodd, S., & Yaqoob, M. (2000) · Kidney International · doi:10.1046/j.1523-1755.2000.00046.x · Cited by 112 · see citing works

Bezafibrate has an antioxidant effect: Peroxisome proliferator-activated receptor α is associated with Cu2+, Zn2+-superoxide dismutase in the liver

Inoue, I., Noji, S., Awata, T., Takahashi, K., Nakajima, T., Sonoda, M., Komoda, T., & Katayama, S. (1998) · Life Sciences · doi:10.1016/s0024-3205(98)00249-5 · Cited by 101 · see citing works

The effects of insulin, glucose and diabetes on prostaglandin production by rat kidney glomeruli and cultured glomerular mesangial cells

Kreisberg, J. I., & Patel, P. Y. (1983) · Prostaglandins Leukotrienes and Medicine · doi:10.1016/0262-1746(83)90097-5 · Cited by 79 · see citing works

Increased oxidative stress in the streptozotocin-induced diabetic apoE-deficient mouse: Changes in expression of NADPH oxidase subunits and eNOS

Ding, H., Hashem, M., & Triggle, C. R. (2007) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2006.12.034 · Cited by 72 · see citing works

PPAR Agonists Amplify iNOS Expression While Inhibiting NF-κB

Cernuda‐Morollón, E., Rodríguez‐Pascual, F., Klatt, P., Lamas, S., & Pérez‐Sala, D. (2002) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000025786.87646.b1 · Cited by 67 · see citing works

Relationship between peroxisome proliferator‐activated receptors (PPARα and PPARγ) and endothelium‐dependent relaxation in streptozotocin‐induced diabetic rats

Kanie, N., Matsumoto, T., Kobayashi, T., & Kamata, K. (2003) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705414 · Cited by 65 · see citing works

Creatinine concentration in plasma from dog, rat, and mouse: a comparison of 3 different methods

Palm, M., & Lundblad, A. (2005) · Veterinary Clinical Pathology · doi:10.1111/j.1939-165x.2005.tb00046.x · Cited by 57 · see citing works

Role of COX-2 in the Enhanced Vasoconstrictor Effect of Arachidonic Acid in the Diabetic Rat Kidney

Quilley, J., & Chen, Y.-J. (2003) · Hypertension · doi:10.1161/01.hyp.0000085650.29823.f2 · Cited by 53 · see citing works

Role of endoperoxides in arachidonic acid‐induced vasoconstriction in the isolated perfused kidney of the rat

Quilley, J., McGiff, J. C., & Nasjletti, A. (1989) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1989.tb11790.x · Cited by 49 · see citing works

Effect of aspirin on experimental diabetic nephropathy.

Moel, D. I., Safirstein, R. L., McEvoy, R. C., & Hsueh, W. (1987) · PubMed · Cited by 45 · see citing works

Arachidonic acid metabolism and urinary excretion of prostaglandins and thromboxane in rats with experimental diabetes mellitus.

Quilley, J., & McGiff, J. C. (1985) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)23316-x · Cited by 43 · see citing works

Induction of cyclo‐oxygenase‐2 in human endothelial cells by SIN‐1 in the absence of prostaglandin production

Eligini, S., Habib, A., Lebret, M., Créminon, C., Levy-Toledano, S., & Maclouf, J. (2001) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704163 · Cited by 38 · see citing works

Inhibition of neuronal nitric oxide synthase ameliorates renal hyperfiltration in streptozotocin-induced diabetic rat

Ito, A., Uriu, K., Inada, Y., Qie, Y.-L., Takagi, I., Ikeda, M., Hashimoto, O., Suzuka, K., Eto, S., Tanaka, Y., et al. (2001) · Journal of Laboratory and Clinical Medicine · doi:10.1067/mlc.2001.116843 · Cited by 34 · see citing works

Effect of Tempol on Renal Cyclooxygenase Expression and Activity in Experimental Diabetes in the Rat

Li, J., Chen, Y.-J., & Quilley, J. (2005) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.076927 · Cited by 33 · see citing works

Early effects of diabetes on inducible nitric oxide synthase in the kidney

Cosenzi, A., Bernobich, E., Bonavita, M., Trevisan, R., Bellini, G., & Campanacci, L. (2002) · Acta Diabetologica · doi:10.1007/s005920200019 · Cited by 29 · see citing works

High glucose increases B1-kinin receptor expression and signaling in endothelial cells

Rodriguez, A. I., Pereira‐Flores, K., Hernández, R., Borić, M. P., & Velarde, V. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.04.127 · Cited by 19 · see citing works

Exogenous Creatinine Clearance Accurately Assesses Filtration Failure in Rat Experimental Nephropathies

Zager, R. A. (1987) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(87)80188-9 · Cited by 16 · see citing works

Effect of inhibition of nitric oxide synthase on renal cyclooxygenase in the diabetic rat

Chen, Y.-J., Li, J., & Quilley, J. (2006) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2006.05.004 · Cited by 12 · see citing works

Ciprofibrate — racemate and enantiomers: Effects of a four-week treatment on male inbred Fischer rats. A biochemical and morphological study

Klinger, W., Lupp, A., Karge, E., Oelschläger, H., Rothley, D., Danz, M., Linss, W., Löbel, S., Deufel, T., Müller, M., et al. (1998) · Experimental and Toxicologic Pathology · doi:10.1016/s0940-2993(98)80010-9 · Cited by 3 · see citing works

Oxidative stress and human health

Rahman, T., Hosen, M. I., Islam, M. M., & Shekhar, H. U. (2012) · Advances in Bioscience and Biotechnology · doi:10.4236/abb.2012.327123 · Cited by 494 · see citing works

Induction of Oxidative Stress in Kidney

Özbek, E. (2012) · International Journal of Nephrology · doi:10.1155/2012/465897 · Cited by 377 · see citing works

Mechanistic insight of diabetic nephropathy and its pharmacotherapeutic targets: An update

Bhattacharjee, N., Barma, S., Konwar, N., Dewanjee, S., & Manna, P. (2016) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2016.08.022 · Cited by 271 · see citing works

Molecular mechanisms in the pathogenesis of diabetic nephropathy: An update

Arora, M. K., & Singh, U. K. (2013) · Vascular Pharmacology · doi:10.1016/j.vph.2013.01.001 · Cited by 241 · see citing works

Efficacy and safety of pemafibrate (K-877), a selective peroxisome proliferator-activated receptor α modulator, in patients with dyslipidemia: Results from a 24-week, randomized, double blind, active-controlled, phase 3 trial

Ishibashi, S., Arai, H., Yokote, K., Araki, E., Suganami, H., & Yamashita, S. (2018) · Journal of Clinical Lipidology · doi:10.1016/j.jacl.2017.10.006 · Cited by 184 · see citing works

Obstructive Sleep Apnea and Diabetic Nephropathy

Tahrani, A. A., Ali, A., Raymond, N. T., Begum, S., Dubb, K., Altaf, Q., Piya, M. K., Barnett, A. H., & Stevens, M. J. (2013) · Diabetes Care · doi:10.2337/dc13-0450 · Cited by 127 · see citing works

Sensory Neurons and Schwann Cells Respond to Oxidative Stress by Increasing Antioxidant Defense Mechanisms

Vincent, A. M., Kato, K., McLean, L. L., Soules, M. E., & Feldman, E. L. (2008) · Antioxidants and Redox Signaling · doi:10.1089/ars.2008.2235 · Cited by 120 · see citing works

Mitochondrial superoxide plays a crucial role in the development of mitochondrial dysfunction during high glucose exposure in rat renal proximal tubular cells

Munusamy, S., & MacMillan-Crow, L. A. (2009) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2009.01.022 · Cited by 106 · see citing works

Evaluation of anti-inflammatory activity of selected medicinal plants used in Indian traditional medication system in vitro as well as in vivo

Shaikh, R. U., Pund, M., & Gacche, R. N. (2015) · Journal of Traditional and Complementary Medicine · doi:10.1016/j.jtcme.2015.07.001 · Cited by 104 · see citing works

PPARα: an emerging therapeutic target in diabetic microvascular damage

Hiukka, A., Maranghi, M., Matikainen, N., & Taskinen, M.-R. (2010) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2010.89 · Cited by 103 · see citing works

High-fat diet-induced renal cell apoptosis and oxidative stress in spontaneously hypertensive rat are ameliorated by fenofibrate through the PPARα–FoxO3a–PGC-1α pathway

Chung, H. W., Lim, J. H., Kim, M. Y., Shin, S. J., Chung, S., Choi, B. S., Kim, H. W., Kim, Y., Park, C. W., & Chang, Y. S. (2011) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfr613 · Cited by 82 · see citing works

Fenofibrate attenuates tubulointerstitial fibrosis and inflammation through suppression of nuclear factor- κ B and transforming growth factor- β 1/Smad3 in diabetic nephropathy

Li, L., Emmett, N. L., Mann, D. R., & Zhao, X. (2010) · Experimental Biology and Medicine · doi:10.1258/ebm.2009.009218 · Cited by 72 · see citing works

Fenofibrate and the kidney: an overview

Kostapanos, M. S., Florentin, M., & Elisaf, M. (2013) · European Journal of Clinical Investigation · doi:10.1111/eci.12068 · Cited by 66 · see citing works

Resveratrol and fenofibrate ameliorate fructose-induced nonalcoholic steatohepatitis by modulation of genes expression

El-Haleim, E. A. A., Bahgat, A. K., & Saleh, S. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i10.2931 · Cited by 65 · see citing works

Associations of Fenofibrate Therapy With Incidence and Progression of CKD in Patients With Type 2 Diabetes

Frazier, R., Mehta, R., Cai, X., Lee, J., Napoli, S., Craven, T., Tuazon, J., Safdi, A., Scialla, J., Susztak, K., et al. (2019) · Kidney International Reports · doi:10.1016/j.ekir.2018.09.006 · Cited by 63 · see citing works

The low dose combination of fenofibrate and rosiglitazone halts the progression of diabetes-induced experimental nephropathy

Arora, M. K., Reddy, K., & Balakumar, P. (2010) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2010.03.002 · Cited by 57 · see citing works

Nuclear receptors in the kidney during health and disease

Libby, A. E., Jones, B. A., Santiago, I. L., Rowland, E., & Levi, M. (2020) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2020.100935 · Cited by 50 · see citing works

Fibrates: Therapeutic potential for diabetic nephropathy?

Kouroumichakis, I., Παπάνας, Ν., Zarogoulidis, P., Liakopoulos, V., Maltezos, E. S., & Mikhailidis, D. P. (2012) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2011.12.007 · Cited by 42 · see citing works

Renal protective effect of chronic inhibition of COX-2 with SC-58236 in streptozotocin-diabetic rats

Quilley, J., Santos, M., & Pedraza, P. L. (2011) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01259.2010 · Cited by 39 · see citing works

Protective Effects of Total Glycoside From Rehmannia glutinosa Leaves on Diabetic Nephropathy Rats via Regulating the Metabolic Profiling and Modulating the TGF-β1 and Wnt/β-Catenin Signaling Pathway

Dai, X., Su, S., Cai, H.-D., Wei, D., Yan, H., Zheng, T., Zhu, Z., Shang, E., Guo, S., Qian, D., et al. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.01012 · Cited by 38 · see citing works

Nuclear hormone receptors in diabetic nephropathy

Wang, X. X., Jiang, T., & Levi, M. (2010) · Nature Reviews Nephrology · doi:10.1038/nrneph.2010.56 · Cited by 38 · see citing works

Effects of combined PPAR-γ and PPAR-α agonist therapy on fructose induced NASH in rats: Modulation of gene expression

El-Haleim, E. A. A., Bahgat, A. K., & Saleh, S. (2016) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2016.01.011 · Cited by 35 · see citing works

Nuclear receptors in renal disease

Levi, M. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2011.04.003 · Cited by 34 · see citing works

Fenofibrate‐induced decrease of expression of CYP2C11 and CYP2C6 in rat

Večeřa, R., Zachařová, A., Orolin, J., Strojil, J., Škottová, N., & Anzenbacher, P. (2011) · Biopharmaceutics & Drug Disposition · doi:10.1002/bdd.774 · Cited by 31 · see citing works

Novel PPAR Pan Agonist, ZBH Ameliorates Hyperlipidemia and Insulin Resistance in High Fat Diet Induced Hyperlipidemic Hamster

Chen, W., Fan, S., Xie, X., Xue, N., Jin, X., & Wang, L. (2014) · PLoS ONE · doi:10.1371/journal.pone.0096056 · Cited by 29 · see citing works

Fenofibrate-induced renal dysfunction, yes or no?

Nematbakhsh, M., Emami, F., Hariri, A., & Matinfar, M. (2020) · Journal of Research in Medical Sciences · doi:10.4103/jrms.jrms_772_19 · Cited by 25 · see citing works

Renoprotective Effects of Fenofibrate via Modulation of LKB1/AMPK mRNA Expression and Endothelial Dysfunction in a Rat Model of Diabetic Nephropathy

Al‐Rasheed, N. M., Al-Rasheed, N. M., Attia, H., Alamin, M. A., Al‐Ajmi, H. N., Hasan, I. H., Mohamad, R. A., & Sinjilawi, N. A.-A. (2015) · Pharmacology · doi:10.1159/000381190 · Cited by 25 · see citing works

Peroxynitrite-induced Nitration of Cyclooxygenase-2 and Inducible Nitric Oxide Synthase Promotes Their Binding in Diabetic Angiopathy

Li, Y., Qi, J., Liu, K., Li, B., Wang, H., & Jia, J. (2010) · Molecular Medicine · doi:10.2119/molmed.2010.00034 · Cited by 25 · see citing works

Fenofibrate attenuates diabetic nephropathy in experimental diabetic rat's model via suppression of augmented TGF- β 1/Smad3 signaling pathway

Al-Rasheed, N. M., Al‐Rasheed, N. M., Alamin, M. A., Hasan, I. H., Al‐Ajmi, H. N., Ahmed, M., & Attia, H. (2016) · Archives of Physiology and Biochemistry · doi:10.3109/13813455.2016.1164186 · Cited by 25 · see citing works

Fenofibrate in cancer: mechanisms involved in anticancer activity

Koltai, T. (2015) · F1000Research · doi:10.12688/f1000research.6153.1 · Cited by 24 · see citing works

Effect of pemafibrate on liver enzymes and shear wave velocity in non-alcoholic fatty liver disease patients

Sugimoto, R., Iwasa, M., Eguchi, A., Tamai, Y., Shigefuku, R., Fujiwara, N., Tanaka, H., Kobayashi, Y., Ikoma, J., Kaito, M., et al. (2023) · Frontiers in Medicine · doi:10.3389/fmed.2023.1073025 · Cited by 23 · see citing works

Evaluation of the incidence and risk factors for development of fenofibrate-associated nephrotoxicity

Attridge, R. L., Linn, W. D., Ryan, L., Koeller, J. M., & Frei, C. R. (2011) · Journal of clinical lipidology · doi:10.1016/j.jacl.2011.08.008 · Cited by 23 · see citing works

Anti-inflammatory activity of anti-hyperlipidemic drug, fenofibrate, and its phase-I metabolite fenofibric acid: in silico, in vitro, and in vivo studies

Prasad, G. S., Govardhan, P., Deepika, G., Vakdevi, V., & Sashidhar, R. B. (2017) · Inflammopharmacology · doi:10.1007/s10787-017-0428-y · Cited by 20 · see citing works

Pharmacokinetic‐Pharmacodynamic Assessment of the Interrelationships Between Tesaglitazar Exposure and Renal Function in Patients With Type 2 Diabetes Mellitus

Hamrén, B., Öhman, K. P., Svensson, M. K. E., & Karlsson, M. O. (2011) · The Journal of Clinical Pharmacology · doi:10.1177/0091270011416937 · Cited by 19 · see citing works

The Microvascular and Macrovascular Benefits of Fibrates in Diabetes and the Metabolic Syndrome: A review.

Malur, P., Menezes, A. R., DiNicolantonio, J. J., O’Keefe, J. H., & Lavie, C. J. (2017) · Europe PMC (PubMed Central) · Cited by 16 · see citing works

Effect of Fenofibrate on the Expression of Inflammatory Mediators in a Diabetic Rat Model

Yeh, P., Wang, L., Chang, S., Yang, W., Yang, C., & Yang, C.-H. (2019) · Current Eye Research · doi:10.1080/02713683.2019.1622020 · Cited by 15 · see citing works

Amelioration of High Fructose Diet-Induced Insulin Resistance, Hyperuricemia, and Liver Oxidative Stress by Combined Use of Selective Agonists of PPAR-α and PPAR-γ in Rats

Farag, M. M., Ashour, E. H., & El-Hadidy, W. F. (2020) · Dubai Medical Journal · doi:10.1159/000506899 · Cited by 15 · see citing works

Managing hypertriglyceridemia for cardiovascular disease prevention: Lessons from the PROMINENT trial

Yamashita, S., Hirano, T., Shimano, H., Tsukamoto, K., Yoshida, M., & Yoshida, H. (2024) · European Journal of Clinical Investigation · doi:10.1111/eci.14227 · Cited by 14 · see citing works

Endothelial nitric oxide synthase impairment is restored by clofibrate treatment in an animal model of hypertension

Cervantes-Pérez, L. G., Ibarra-Lara, L., Escalante, B., del Valle‐Mondragón, L., Vargas‐Robles, H., Pérez‐Severiano, F., Pastelı́n, G., & Sánchez-Mendoza, A. (2012) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2012.04.006 · Cited by 12 · see citing works

Switching from Conventional Fibrates to Pemafibrate Has Beneficial Effects on the Renal Function of Diabetic Subjects with Chronic Kidney Disease

Izumihara, R., Nomoto, H., Kito, K., Yamauchi, Y., Omori, K., Shibayama, Y., Yanagiya, S., Miya, A., Kameda, H., Cho, K. Y., et al. (2024) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2023.0370 · Cited by 11 · see citing works

Comparative analysis of fat and muscle proteins in fenofibratefed type II diabetic OLETF rats: the fenofibrate-dependent expression of PEBP or C11orf59 protein

Hahm, J. R., Ahn, J.-S., Noh, H.-S., Baek, S.-M., Ha, J., Jung, T. S., An, Y., Kim, D.-K., & Kim, D. R. (2010) · BMB Reports · doi:10.3858/bmbrep.2010.43.5.337 · Cited by 8 · see citing works

Development of novel nanoemulsion of pioglitazone used in the treatment of diabetes and its gel form for the treatment of skin diseases

Ahmad, N., Ansari, K. A., Alamoudi, M. K., Ullah, Z., Haque, A., & Ibrahim, H. O. (2024) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2024.106096 · Cited by 7 · see citing works

Devil’s Triangle in Kidney Diseases: Oxidative Stress, Mediators, and Inflammation

Balat, A., Resić, H., Bellinghieri, G., & Anarat, A. (2012) · International Journal of Nephrology · doi:10.1155/2012/156286 · Cited by 7 · see citing works

Treatment of diabetic rats with a peroxynitrite decomposition catalyst prevents induction of renal COX-2

Chen, Y.-J., Santos, M., & Quilley, J. (2011) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00768.2010 · Cited by 7 · see citing works

Fenofibrate and renal disease: clinical effects in diabetes

Ting, R.-D., & KEECH, A. C. (2013) · Clinical Lipidology · doi:10.2217/clp.13.69 · Cited by 5 · see citing works

Physicochemical and pharmacodynamic evaluation of pioglitazone binary systems with hydrophilic carriers

Ibrahim, M. A., Ela, A. E. S. F. A. E., Al-Rasheed, N. M., & Alamin, M. A. (2019) · Pharmaceutical Development and Technology · doi:10.1080/10837450.2019.1616300 · Cited by 5 · see citing works

Combined effects of a pharmaceutical pollutant, gemfibrozil, and abiotic stressors (warming and air exposure) on cellular stress responses of the blue mussels Mytilus edulis

Falfushynska, H., Sokolov, E. P., & Sokolova, I. M. (2025) · Aquatic Toxicology · doi:10.1016/j.aquatox.2024.107233 · Cited by 4 · see citing works

Antioxidant SMe1EC2 may attenuate the disbalance of sodium homeostasis in the organism induced by higher intake of cholesterol

Mézešová, L., Javorková, V., Vlkovičová, J., Kyseľová, Z., Navarová, J., Bezek, Š., & Vrbjar, N. (2012) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-012-1281-3 · Cited by 4 · see citing works

Combination of PPAR-α Agonist and DPP-4 Inhibitor: A Novel Therapeutic Approach in the Management of Diabetic Nephropathy

Arora, M. K. (2013) · Journal of Diabetes & Metabolism · doi:10.4172/2155-6156.1000320 · Cited by 4 · see citing works

Safety and efficacy modelling in anti-diabetic drug development.

Hamrén, B. (2008) · KTH Publication Database DiVA (KTH Royal Institute of Technology) · Cited by 3 · see citing works

Causal relationship between obstructive sleep apnea and diabetic nephropathy: bidirectional and multivariable Mendelian randomization study

Zhao, L. D., Liu, Z., Zhang, R., Li, Y., & Zhang, X. (2025) · Renal Failure · doi:10.1080/0886022x.2025.2569086 · Cited by 2 · see citing works

Nuclear receptors as therapeutic targets in metabolic and cardiovascular disorders

Li, F., Chen, Q., Dai, Y., & Lu, L. (2025) · iScience · doi:10.1016/j.isci.2025.114042 · Cited by 1 · see citing works

Effect of Combined Fenofibrate and Nicotinamide on Oxidative Stress and Inflammatory Cytokines Involved in Cisplatin-Induced Nephrotoxicity in Rats

Allah, O. M. A., El‐Din, A. A. I. S., & Debakey, F. E. (2014) · American Journal of Pharmacology and Toxicology · doi:10.3844/ajptsp.2014.206.222 · Cited by 1 · see citing works

Andrographolide: A Renoprotective Diterpene from Andrographis Paniculata (Burm. f.) Nees

Singh, P., Srivastava, M. M., Hazra, D. K., & Khemani, L. D. (2011) · Springer eBooks · doi:10.1007/978-3-642-23394-4_7 · Cited by 1 · see citing works

EFFECT OF IRAQI ETHANOLIC PROPOLIS EXTRACTS ON THE REACTIVE NITROGEN SPECIES AND GENOTYPE ALTERATION IN DIABETIC NEPHROPATHY RATS

Zghair, A. N., & Jabir, F. A. (2015) · International Journal of Pharma and Bio Sciences

Nano-formulation of Tabernaemontana divericata extract for the management of inflammation

Nawale, S., Tarana, K., Kedar, K. A., & Raju, M. G. (2023) · Medicinal Plants - International Journal of Phytomedicines and Related Industries · doi:10.5958/0975-6892.2023.00041.2

Design of the Japan Kidney Association-Pemafibrate Intervention for Chronic Kidney Disease patients Study (JKAPI-CKD Study)

Kinguchi, S., Tamura, K., Yano, Y., Nangaku, M., Isaka, Y., Maruyama, S., Kanegae, H., Heerspink, H. J. L., Nakagawa, N., Nishio, S., et al. (2026) · Clinical Kidney Journal · doi:10.1093/ckj/sfag053

Renal Outcomes of Triglyceride-Targeting Lipid-Lowering Therapies versus Statins in Patients with CKD

Naim, M. A. A. Z., Thomas, F., Streja, E., Davis, R. L., Kalantar‐Zadeh, K., Sumida, K., & Kovesdy, C. P. (2026) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.0000001188

Oxidative Stress in Immunotoxicity: A Biochemical Foe or a Friend?

Okopi, A., Isaac, O. T., & Agi, A. B. (2021) · International Journal of Innovative Science and Research Technology (IJISRT) · doi:10.38124/ijisrt/21mar405

Treatment of diabetic rats with a peroxynitrite decomposition catalyst prevents induction of renal COX-2

Chen, Y.-J., Santos, M., & Quilley, J. (2011) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00768.2010 · Cited by 7 · see citing works

Fenofibrate improves renal function by amelioration of NOX‐4, IL‐18, and p53 expression in an experimental model of diabetic nephropathy

Yaribeygi, H., Mohammadi, M. T., Rezaee, R., & Sahebkar, A. (2018) · Journal of Cellular Biochemistry · doi:10.1002/jcb.27055 · Cited by 70 · see citing works

Effect of inhibition of nitric oxide synthase on renal cyclooxygenase in the diabetic rat

Chen, Y.-J., Li, J., & Quilley, J. (2006) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2006.05.004 · Cited by 12 · see citing works

Effect of Tempol on Renal Cyclooxygenase Expression and Activity in Experimental Diabetes in the Rat

Li, J., Chen, Y.-J., & Quilley, J. (2005) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.076927 · Cited by 33 · see citing works

PPAR-Alpha Agonist Fenofibrate Induces Renal CYP Enzymes and Reduces Blood Pressure and Glomerular Hypertrophy in Zucker Diabetic Fatty Rats

Zhao, X., & Li, L. (2008) · American Journal of Nephrology · doi:10.1159/000116885 · Cited by 46 · see citing works